Aurenar
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$5.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aurenar operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Seed round in July 2026.
Aurenar is a medical device company that develops a non-invasive, single-use neuromodulation platform designed to reduce life-threatening complications in intensive care unit patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurenar Comparables
Compare Aurenar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evren Technologies | 65% | |
| Spark Biomedical Inc | 62% | |
| Surf Therapeutics | 61% |
For institutional investors. Book with your work email.
Aurenar Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aurenar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaleida Capital | Seed |
| Solas BioVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 1262% MoM, reaching 1.4K.
- Aug 16, 2026
Grew 30% QoQ from 10 to 13 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 21, 2026
On Sep 21st '26, Aurenar is developing a neuromodulation device aimed specifically at stroke recovery and raises $5.7M to accelerate its development.
For institutional investors. Book with your work email.
Aurenar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aurenar's valuation, stock price, and market status.
Is Aurenar a public or private company?
Aurenar is a private company.
What is the current stock price of Aurenar?
Aurenar is a private company, so its shares have no public market price. Caplight tracks Aurenar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aurenar worth (valuation)?
Valuation information for Aurenar is not publicly available.
Can I buy Aurenar stock?
Aurenar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aurenar's last funding round?
Aurenar's most recent funding round was Seed on July 28, 2026.
Who are the main investors in Aurenar?
Key investors in Aurenar include Solas BioVentures.
Will Aurenar IPO soon?
No public IPO plans have been announced for Aurenar.
How can I track Aurenar secondary market activity?
Caplight tracks bids, offers, and trades in Aurenar's shares on secondary markets.